Metagenomic Next-Generation Sequencing (mNGS): SARS-CoV-2 as an Example of the Technology's Potential Pediatric Infectious Disease Applications. (24th December 2021)

• Record Type: Journal Article
• Authors: Handel, Andrew S; Muller, William J; Planet, Paul J
• Is Part Of: Journal of the Pediatric Infectious Diseases Society. Volume 10(2021)Supplement 4
• Page Start: S69
• Page End: S70
• Publication Date: 2021-12-24
• Subjects: diagnostics -- infectious diseases -- metagenomic next-generation sequencing -- pediatrics -- SARS-CoV-2; Communicable diseases in children -- Periodicals; Children -- Diseases -- Periodicals; 618.929
• DOI: 10.1093/jpids/piab108
• Languages: English
• ISSNs: 2048-7193

Abstract

Abstract: Metagenomic next-generation sequencing (mNGS) has emerged as a potentially powerful tool in clinical diagnosis, hospital epidemiology, microbial evolutionary biology, and studies of host-pathogen interaction. The SARS-CoV-2 pandemic provides a framework for demonstrating the applications of this technology in each of these areas. In this Supplement, we review applications of mNGS within the discipline of pediatric infectious diseases.